Brief: Biothera Pharmaceuticals and Merck further expand research collaboration

Procter & Gamble Health

05/12/2016 14:30

Dec 5 (Reuters) - Merck Ltd  MERK.NS  
    * Biothera Pharmaceuticals and Merck further expand research 
collaboration to include Phase 2 clinical trial in head and neck 
cancer 
    * Biothera Pharmaceuticals-goal of new phase 2 study will be 
to determine potential of imprime PGG, to increase patient 
responses to keytruda 
 
Source text for Eikon:  ID:nGNXNNIQLa  
Further company coverage:  MERK.NS  
 
 ((Bangalore.newsroom@thomsonreuters.com;))